Vermont Hydro Projects Seek License Extensions on Otter Creek
Published Date: 12/23/2025
Notice
Summary
Green Mountain Power wants to extend the licenses for two hydroelectric projects on Otter Creek in Vermont. This means they can keep running these power plants longer without changing how much electricity they produce. If you live nearby or care about the environment, you have until January 20, 2026, to share your thoughts or get involved before any decisions are made.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Public Comment Deadline — Jan 20, 2026
You have until January 20, 2026, at 5:00 p.m. Eastern Time to file comments, protests, or motions to intervene about Green Mountain Power's applications for the Weybridge (P-2731-045) and Middlebury Lower (P-2737-028) projects. Filings can be made electronically via FERC's eFiling or eComment systems or by mail and must include the docket numbers.
License Extension Keeps Plants Operating to 2041
Green Mountain Power requests extending the Weybridge and Middlebury Lower licenses from July 31, 2031, to July 31, 2041 so the company can recoup rehabilitation costs. The request would allow the projects to continue operating without changing how much electricity they produce; the authorized installed capacity remains 3.0 megawatts.
Turbine Upgrade With Minimal Disturbance
The licensee plans turbine runner replacements at both projects and proposes replacing the Weybridge turbine runner; the upgrade would keep installed capacity at 3.0 megawatts but reduce the powerhouse maximum hydraulic capacity from 1,600 cubic feet per second to 1,590 cfs. All proposed construction at Weybridge would occur inside the existing powerhouse, be isolated from the river, use the existing access road, and would not require ground disturbance.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17101, Georgia Power Company; Notice of Application for Temporary Variance Accepted for Filing, Soliciting Comments, Motions To Intervene, and Protests
Georgia Power Company asked for a temporary change to rules at their Flint River Hydroelectric Project in Georgia. This could affect water quality rules and needs approval from state agencies. People have until September 17, 2026, to share their thoughts or get involved before any decisions are made.
2026-17103, Seefeld Corporation: Notice of Application for Surrender of Exemption Accepted for Filing, Soliciting Comments, Motions To Intervene, and Protests
Seefeld Corporation wants to give up its special exemption for the Smith Creek Hydroelectric Project in Washington. This change could affect local water quality rules and needs approval from the Washington Department of Ecology. People have until September 17, 2026, to share their thoughts or get involved before the decision moves forward.
2026-16925, Commission Information Collection Activities (FERC-725U); Comment Request; Extension
In compliance with the requirements of the Paperwork Reduction Act of 1995, the Federal Energy Regulatory Commission (Commission or FERC) is soliciting public comment on the currently approved information collection FERC-725U (1902-0274), Mandatory Reliability Standards for the Bulk Power System; CIP Reliability Standards. There are no proposed changes to the reporting requirements. The comment period ended on July 27, 2026, with no comments received.
2026-16739, Venture Global CP2 LNG, LLC, Venture Global CP Express, LLC; Notice of Scoping Period Requesting Comments on Environmental Issues for the Proposed CP2 LNG Expansion Project, and Notice of Public Scoping Sessions
2026-16616, Regulatory Agenda
We are publishing our regulatory agenda (the Agenda) in accordance with Public Law 96-354, "The Regulatory Flexibility Act," and Executive Order 12866, "Regulatory Planning and Review." FERC's complete Agenda, available on OMB's website at https://www.reginfo.gov, is a compilation of all rulemaking activities on which we have recently completed action or have proposed or are considering action. Our last Agenda was provided in May 2025 and in this current agenda, we have listed 42 rulemaking activities. We also note that the Agency has one inactive rulemaking that is not listed in this Agenda. This issuance of our Agenda contains ten (10) Pre-Rules, eleven (11) Notice of Proposed Rules, eight (8) Final Rules, and thirteen (13) Completed activities. Four (4) rulemakings are Section 3(f)(1) Significant; two (2) are Other Significant; one (1) is a routine rulemaking activity; two (2) are administrative, and thirty-two (32) are Substantive, Nonsignificant rulemaking activities.
2026-16637, Combined Notice of Filings
The Federal Energy Regulatory Commission got new filings from several natural gas pipeline companies about rate changes and rule updates. These changes could affect pipeline rates starting as soon as July 9, 2026, and some compliance updates kick in January 1, 2027. If you want to speak up or get involved, you need to comment by late August 2026.
Previous / Next Documents
Previous: 2025-23703, Combined Notice of Filings
The Federal Energy Regulatory Commission got new filings from natural gas companies about rate changes and refunds. If you’re involved or interested, you have until late December or early January to comment or join the discussion. These updates could affect how much people pay or get refunded for natural gas services starting early 2026.
Next: 2025-23707, Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability
The FDA just released final guidance to help drug companies and FDA staff settle scientific disagreements through formal dispute resolution and hearings. This update affects anyone involved in drug reviews under Section 505G and aims to make the process clearer and fairer. The guidance is effective now, helping save time and avoid costly delays in drug approvals.